Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial

BACKGROUND: Sulfamethoxazole-trimethoprim (SMX/TMP) is a standard drug for the prophylaxis of Pneumocystis pneumonia (PJP) in immunosuppressed patients with systemic rheumatic diseases, but is sometimes discontinued due to adverse events (AEs). The objective of this non-blinded, randomized, 52-week...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Res Ther
Main Authors: Utsunomiya, Masako, Dobashi, Hiroaki, Odani, Toshio, Saito, Kazuyoshi, Yokogawa, Naoto, Nagasaka, Kenji, Takenaka, Kenchi, Soejima, Makoto, Sugihara, Takahiko, Hagiyama, Hiroyuki, Hirata, Shinya, Matsui, Kazuo, Nonomura, Yoshinori, Kondo, Masahiro, Suzuki, Fumihito, Tomita, Makoto, Kihara, Mari, Yokoyama, Waka, Hirano, Fumio, Yamazaki, Hayato, Sakai, Ryoko, Nanki, Toshihiro, Koike, Ryuji, Kohsaka, Hitoshi, Miyasaka, Nobuyuki, Harigai, Masayoshi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5241919/
https://ncbi.nlm.nih.gov/pubmed/28100282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-016-1206-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados